Veterinary Medicines

Benestermycin vet. Intramammär salva

Authorised
  • Penethamate hydriodide
  • Framycetin sulfate
  • Benethamine penicillin
Download as PDF

Product identification

Medicine name:
Benestermycin vet. Intramammär salva
Active substance:
  • Penethamate hydriodide
  • Framycetin sulfate
  • Benethamine penicillin
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Penethamate hydriodide
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Framycetin sulfate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benethamine penicillin
    280.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        37
        day
      • Meat and offal
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC25
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
  • Lohmann Pharma Herstellung GmbH
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 8804
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 20/04/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
Download